CONNECTing to LungCare
概览
- 阶段
- 不适用
- 干预措施
- Saliva Collection
- 疾病 / 适应症
- Smoking Cessation
- 发起方
- University of California, San Francisco
- 入组人数
- 147
- 试验地点
- 1
- 主要终点
- Retention rates
- 状态
- 招募中
- 最后更新
- 上个月
概览
简要总结
This study evaluates a smoking cessation intervention (CONNECTing to LungCare) for improving shared decision-making conversations about smoking cessation and lung cancer screening between patients and providers. Shared decision making is a patient care model in which providers offer information regarding risks and benefits, patients express their values and preferences, and then healthcare decisions are jointly discussed between the patient and provider. Patient education, aided by decision support tools, can increase patients' knowledge, decrease their decisional conflict, promote decision making, and improve the patients' perception of risk. CONNECTing to LungCare is an interactive education intervention that addresses lung cancer screening and smoking cessation and provides participants with a tailored summary that may make them more likely to have shared decision-making discussions with their providers about smoking cessation and lung cancer screening.
详细描述
PRIMARY OBJECTIVES: Aim 1: Development of the smoking cessation and LCS intervention, CONNECTing to LungCare. Aim 2: Test CONNECTing to Lung Care for Feasibility and Acceptability (N=120) Aim 3: To qualitatively evaluate feasibility and acceptability of the intervention and study procedures from the perspectives of patients, providers, staff and administrators and other stakeholders. OUTLINE: BETA TESTING: Participants interact with the CONNECTing to LungCare intervention and provide feedback in support of intervention refinement. FEASIBILITY TRIAL: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive the CONNECTing to LungCare intervention, including education about the benefits and risks of LCS and the importance of shared decision making, computerized assessments of the participant's smoking status, readiness to quit and concerns about quitting, and video segments tailored to the participant's responses to assessment questions, prior to their primary care appointment. Participants and their providers receive a tailored summary of the participant's concerns and barriers to quitting to enhance motivation for smoking cessation and shared decision making discussions. Participants then receive up to 3 follow-up phone calls over 10-15 minutes each encouraging them to follow up with their provider, to complete the shared decision-making conversation, obtain LCS if appropriate, and access smoking cessation resources. Participants may also receive brief, tailored follow-up text messages that include links to video segments or cessation resources 1-3 times weekly. GROUP II: Participants receive usual care from their provider at their primary care appointment. After completion of study intervention, participants are followed up at 1 and 3 months.
研究者
入排标准
入选标准
- •English, Spanish and Cantonese speaking
- •Age \>= 18 years old
- •Primary care patients at the University of California, San Francisco (UCSF) General Internal Medicine (GIM) clinics
- •Must be current smokers and/or candidates for Lung Cancer Screening (LCS).
- •Key Informant Interviews:
- •\- Must be working in one of the clinics participating in CONNECTing to LungCare.
排除标准
- •Not a current smoker
研究组 & 干预措施
Feasibility trial, Group II (usual care)
Participants receive usual care from their provider at their primary care appointment.
干预措施: Saliva Collection
Feasibility trial, Group II (usual care)
Participants receive usual care from their provider at their primary care appointment.
干预措施: Survey Administration
Feasibility trial, Group I (CONNECTing to LungCare)
Participants receive the CONNECTing to LungCare intervention, including education about the benefits and risks of LCS and the importance of shared decision making, computerized assessments of the participant's smoking status, readiness to quit and concerns about quitting, and video segments tailored to the participant's responses to assessment questions, prior to their primary care appointment. Participants and their providers receive a tailored summary of the participant's concerns and barriers to quitting to enhance motivation for smoking cessation and shared decision-making discussions. Participants then receive up to 3 follow-up phone calls over 10-15 minutes each encouraging them to follow up with their provider, to complete the shared decision-making conversation, obtain LCS if appropriate, and access smoking cessation resources. Participants may also receive brief, tailored follow-up text messages that include links to video segments or cessation resources 1-3 times weekly.
干预措施: Survey Administration
Feasibility trial, Group II (usual care)
Participants receive usual care from their provider at their primary care appointment.
干预措施: Smoking Cessation Intervention
Beta testing (CONNECTing to LungCare, feedback)
Participants interact with the CONNECTing to LungCare intervention and provide feedback in support of intervention refinement.
干预措施: Smoking Cessation Intervention
Beta testing (CONNECTing to LungCare, feedback)
Participants interact with the CONNECTing to LungCare intervention and provide feedback in support of intervention refinement.
干预措施: Survey Administration
Feasibility trial, Group I (CONNECTing to LungCare)
Participants receive the CONNECTing to LungCare intervention, including education about the benefits and risks of LCS and the importance of shared decision making, computerized assessments of the participant's smoking status, readiness to quit and concerns about quitting, and video segments tailored to the participant's responses to assessment questions, prior to their primary care appointment. Participants and their providers receive a tailored summary of the participant's concerns and barriers to quitting to enhance motivation for smoking cessation and shared decision-making discussions. Participants then receive up to 3 follow-up phone calls over 10-15 minutes each encouraging them to follow up with their provider, to complete the shared decision-making conversation, obtain LCS if appropriate, and access smoking cessation resources. Participants may also receive brief, tailored follow-up text messages that include links to video segments or cessation resources 1-3 times weekly.
干预措施: Smoking Cessation Intervention
Feasibility trial, Group I (CONNECTing to LungCare)
Participants receive the CONNECTing to LungCare intervention, including education about the benefits and risks of LCS and the importance of shared decision making, computerized assessments of the participant's smoking status, readiness to quit and concerns about quitting, and video segments tailored to the participant's responses to assessment questions, prior to their primary care appointment. Participants and their providers receive a tailored summary of the participant's concerns and barriers to quitting to enhance motivation for smoking cessation and shared decision-making discussions. Participants then receive up to 3 follow-up phone calls over 10-15 minutes each encouraging them to follow up with their provider, to complete the shared decision-making conversation, obtain LCS if appropriate, and access smoking cessation resources. Participants may also receive brief, tailored follow-up text messages that include links to video segments or cessation resources 1-3 times weekly.
干预措施: Saliva Collection
结局指标
主要结局
Retention rates
时间窗: Up to 1 year
The percentage of participants who joined the study and completed the program will be reported.
Adherence rates
时间窗: Up to 1 year
The percentage of participants who joined the study and completed all tasks within the program will be reported.
Recruitment rate
时间窗: Up to 1 year
The percentage of participants who were contacted and joined the study will be reported.
Overall time required to recruit to the target sample size (Feasibility Cohort)
时间窗: Up to 1 year
The overall time in weeks required to recruit participants for the feasibility cohort will be reported.
Number of eligible participants
时间窗: Up to 1 year
The number of eligible participants required to recruit the required sample size will be reported
次要结局
- Shared decision making about LCS(Up to 3 months)
- Lung cancer screening (LCS) rates(Up to 3 months)
- Smoking cessation rates(At 3 months)